Biotechnology & Pharmaceuticals
With a proven history of managing complex filings across more than 100 jurisdictions, we provide omnidirectional counseling spanning global prosecution, invalidation trials, high-stakes infringement actions, licensing, and bio-tech valuation.
Our seasoned team holds expansive experience across a myriad of cutting-edge biopharmaceutical fields, including: Small Molecule Therapeutics, Antibody and Protein Therapeutics, Biosimilars and Biobetters, Cell and Gene Therapy (CGT), mRNA and Nucleic Acid-Based Therapeutics, Vaccine Platforms, Drug Delivery Systems (DDS), Novel Formulations and Crystalline Forms, Diagnostic Compositions, Biomarkers, Precision Medicine, Organoids, Stem Cell Application Technologies. In Advanced biotechnology, our expertise extends to Synthetic Biology, Bioinformatics, AI-Driven Drug Discovery, Gene Editing Technologies, Microbial/Enzyme Engineering, Industrial/Environmental Biotechnology, Cosmetics, Health Functional Foods, and Agricultural/Food Biotechnology.
By carefully balancing the unique biological characteristics of each asset with stringent global regulatory pathways (such as the FDA or MFDS), LEE & MOCK IP ensures its clients’ core scientific breakthroughs are locked down as highly competitive, monetization-ready global rights.
